Smaller hospitals win Government support

October 24, 2003

Smaller local hospitals are to become important centres for developing patient-centred care in a reversal of what the Government calls …

14 more PCTs to join pharmaceutical services revolution

October 24, 2003

Fourteen PCTs have been given the go-ahead to develop new and innovative services and improve patient services through community pharmacists.Local …

J&J strengthens biotech business

October 24, 2003
Janssen, Janssen Cilag, Johnson & Johnson, Scios

 Johnson & Johnson is to expand its biotech capabilities with a $2.4 billion purchase of US company Scios.The deal, still …

vCJD caution prompts Serono product withdrawal

October 24, 2003

Serono is to withdraw one of its hormone products from the UK after a case of variant Creutzfeldt-Jakob disease was …

Iressa filed in Europe amid safety concerns

October 24, 2003

AstraZeneca has submitted its lung cancer drug Iressa for approval in Europe, despite concerns about side-effects.The novel drug was launched …

New trial for treatment-resistant HIV

October 24, 2003

Boehringer Ingelheim has begun a global phase III trial for a new drug it hopes will be effective for HIV …

Former ImClone chief fined $800,000 for insider dealing

October 24, 2003

Former ImClone boss Samuel Waksal has agreed to pay $800,000 to settle some of the charges brought against him by …

GSK puts new slant on Garnier pay battle

October 24, 2003

GlaxoSmithKline is to raise the issue of Chief Executive Jean-Pierre Garnier's pay once again this week, saying it is intended …

EU to conclude Pfizer-Pharmacia review in coming weeks

October 24, 2003

The European Commission has restarted its review of Pfizer's merger with Pharmacia, and now expects to complete the investigation of …

Conflict of interests halt Seroxat inquiry

October 24, 2003

If you were to ask leading CRO executives they would tell you that blue chip pharma companies outsource their critical …

AstraZeneca files first for European bipolar disorder

October 24, 2003

AstraZeneca have filed the first European marketing application for an atypical antipsychotic as a treatment for manic episodes related to …

Lilly’s well-planned campaign launches ‘spontaneity’ ED drug

October 24, 2003

Eli Lilly have launched Cialis, the first serious rival to blockbuster erectile dysfunction drug Viagra amid a flurry of media …

Aventis cautious as growth slows

October 24, 2003

Aventis has reined in its 2003 forecasts and warned investors that the pace of its growth would slow to a …

Elan shows $2.4bn loss for 2002

October 24, 2003

Irish pharmaceutical company Elan made a larger than expected loss of $2.39 billion last year.Shares in the troubled company fell …

Pfizer rivals face uphill struggle

October 24, 2003

Pharmaceutical companies attempting to keep up with Pfizer's industry lead have a battle on their hands, according to analysts Datamonitor.New …

The Gateway to Local Adoption Series

Latest content